Evidence map›Paper›PMID 32498216›Full record

Trial reportNutrients2020

Difensil Immuno Reduces Recurrence and Severity of Tonsillitis in Children: A Randomized Controlled Trial.

Arianna Di Stadio, Antonio Della Volpe, Fiammetta M Korsch, Antonietta De Lucia, Massimo Ralli, Francesco Martines, Giampietro Ricci

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arianna Di StadioDepartment of Otolaryngology, University of Perugia, 06129 Perugia, Italy.
Antonio Della VolpeOtology and Cochlear Implant Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
Fiammetta M KorschOtology and Cochlear Implant Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
Antonietta De LuciaOtology and Cochlear Implant Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
Massimo RalliSense Organs Department, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-8776-0421
Francesco MartinesBiomedicine, Neuroscience and Advanced Diagnostics Department, University of Palermo, 90127 Palermo, Italy.
Giampietro RicciDepartment of Otolaryngology, University of Perugia, 06129 Perugia, Italy.
University of Perugia · ITSapienza University of Rome · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral supplements (OS) support the immune system in fighting upper airways infection. This study aimed to analyze the effect of Difensil Immuno (DI) on the recurrence of tonsillitis and fever in children. A multicentric randomized clinical trial was conducted. One-hundred and twenty children with chronic tonsillitis were randomly assigned to group A, B or control. Patients in group A were treated with 10 mL of DI for 90 consecutive days, patients in group B underwent treatment with 15 mL of DI for 45 consecutive days. The following data were collected at baseline (T0), T1 and T2: tonsillitis and fever episodes, tonsillar volume, blood test results. One-way ANOVA was used to analyze within and between variances. Patients in group A and B statistically improved their clinical parameters (episode of tonsillitis and fever, tonsillar volume) when compared to control group both at T1 and T2. However, T1 variances were more consistent in group A than in group B. All patients in the study groups improved their clinical outcomes. No statistically significant variances were observed in blood parameters both at T1 and T2. Our results suggest that children treated with DI had fewer episodes of tonsillitis and fever and a reduction in their tonsillar volume.

Indexed as

Dietary SupplementsSecondary PreventionAdjuvants, ImmunologicChildChild, PreschoolFemaleFeverGalactansHumansImmune SystemLactobacillus acidophilusMaleSambucus nigraSeleniumSeverity of Illness IndexTonsillitisAdjuvants, ImmunologicarabinogalactanGalactansSeleniumVitaminsZincimmune stimulationimmune systemoral supplementtonsillitistreatment

Identifiers

PMID32498216
PMCPMC7352765
OpenAlexW3032433598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.